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Purpose: To determine if decline in corpus callosum
(CC) white matter integrity in patients with amyotrophic
lateral sclerosis (ALS) is localized to motor-related areas.
Materials and Methods: Twenty-one ALS patients and
21 controls participated. Diffusion tensor images (DTI)
were acquired using 3 Tesla (T) MRI. Tract-based spatial
statistics were used to examine whole-brain white matter
damage. A segmentation schema was used to define CC
volumes-of-interest (VOI). Fractional anisotropy (FA) and
radial- and axial-diffusivity (RD, AD) were extracted from
VOIs and compared between groups. DTI measurements
in motor-related Area III were tested for correlation with
symptoms and disease duration.
Results: Extracted FA values from CC VOIs were
reduced in ALS patients (P0.0001), particularly in Areas
II and III (P0.01). Reduced FA in Area III correlated with
disease symptomology (P0.05) and duration (P0.02).
Between-group whole-brain comparisons (P0.05, cor-
rected) showed reduced FA and increased RD throughout
white matter regions including the CC, corona radiata,
and internal capsule. AD was increased in the left corona
radiata and internal and external capsules.
Conclusion: FA in motor-related regions of the CC is
more affected than other CC areas in ALS patients. Micro-
structural pathology of transcallosal fiber tracts may repre-
sent a future component of an imaging biomarker for ALS.
Key Words: DTI; corpus callosum; amyotrophic lateral
sclerosis
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AMYOTROPHIC LATERAL SCLEROSIS (ALS) is a pro-
gressive neurodegenerative disease affecting both
upper- and lower-motor neurons. There are active
efforts in the field of neuroimaging to discover a bio-
marker to aid in earlier diagnosis, improve the under-
standing of motor-neuron degeneration, and perhaps
serve as an outcome measure for disease-modifying
therapies. Unfortunately, early diagnosis of ALS has
proven elusive as clinical confirmation can only occur
after both upper (UMN) and lower motor neuron
(LMN) involvement are detected by neurologic exami-
nation, which often occurs at a time point of advanced
pathology (1). While noninvasive neurophysiologic
techniques exist to detect subclinical LMN dysfunc-
tion, there is no sensitive tool that can similarly dis-
tinguish UMN dysfunction to aid in early diagnosis
(2). For these reasons, much attention has turned to-
ward neuroimaging as a means of identifying UMN
involvement (3).
Particular interest in the use of diffusion tensor
imaging (DTI) to identify UMN involvement in ALS has
been growing. DTI research to date has largely repli-
cated findings from postmortem studies indicating
widespread microstructure deterioration along the
UMNs of the corticospinal tract and corpus callosum
(CC), validating this method as a valuable in vivo
marker of the disease process (4–7). The CC in
patients with ALS has consistently shown DTI
changes, with decreased fractional anisotropy (FA)
and increased radial and axial diffusivity (RD, AD)
compared with control subjects (8). These changes
may correspond to degeneration of transcallosal fibers
passing between primary motor cortices observed at
1.5T (9). However, it has yet to be determined whether
the mid-body motor fibers of the CC are more strongly
affected in ALS when compared with other portions of
the CC.
The goal of our study was to systematically test the
hypothesis that transcallosal fibers passing between
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primary motor cortices are especially affected com-
pared with other regions of the CC using DTI. We
examined the relationship between this microstruc-
tural measure and clinical evaluation of disease sta-
tus. Additionally, we used tract-based spatial
statistics (TBSS) to examine the whole-brain pattern
of white matter changes. We highlight this point as
TBSS-based normalization removes placement var-
iance as seen in previous work using VOIs or tracking
seed locations defined in patient space (10,11).
Finally, this present work was performed at 3.0T com-
pared with 1.5T in previous work (9), and DTI at this
higher field strength has been shown to have
increased signal to noise ratio in areas such as the
CC and corticospinal tract (12).
MATERIALS AND METHODS
Study Participants
Patients diagnosed with definite ALS by a neuromus-
cular physician using El Escorial criteria were
recruited from and followed by the Motor Neuron Dis-
ease Center. Twenty-one ALS patients (13 male; mean
age, 59.8 years), 15 with limb-onset ALS (11 male;
mean age, 58.6 years) and 5 patients with bulbar-
onset ALS (2 male; mean age 63.4 years), were
included in the study. All patients were ambulatory;
did not have hemiplegia, dysphagia, dyspnea, or re-
spiratory failure; and were without other neurologic or
psychiatric disease. Patients with ALS were compared
with 21 healthy controls without psychiatric or neuro-
logic disorders (11 male; mean age, 56.5 years). Con-
trols were recruited from the local community by flyer
and Internet advertisements. A portion of these partic-
ipants were involved in a previous published study
(13). The University of Michigan Medical School Insti-
tutional Review Board approved this study, and all
participants gave written informed consent before
their participation in any part of the investigation.
Clinical Measures
The revised ALS Functional Rating Scale (ALSFRS-r), a
12-question validated rating instrument with a maxi-
mum score of 48, was administered to all patients within
7 days of their scanning session to assess motor function
(14). The Edinburgh Inventory was used to determine
hand dominance (15). Hand strength was measured with
a hand-grip dynamometer averaged across three trials
on both hands. Hand strength disparity was recorded as
the absolute value of the difference between dominant
and nondominant hand strength.
Image Acquisition
MRI of all patients and controls was acquired using a
GE 3T Excite 2 scanner (General Electric, Milwaukee,
WI). Three-plane localizer images were acquired, fol-
lowed by a 40 slice T1-weighted anatomic overlay (echo
time, TE¼5.7 ms; repetition time, TR¼250 ms; 220
mm field-of-view, FOV; 256  256 matrix; 3 mm slice
thickness). Subjects lay resting for a 5-min diffusion
tensor scan (echo-planar imaging, 220 mm FOV, 128
 128 matrix, TE¼70 ms, TR¼9000 ms, b¼800 s/
mm2). Within each scan, a b¼0 image and 15 noncol-
linear diffusion-weighted images were collected (16).
Diffusion Tensor Imaging
Preprocessing
All DTI processing was done using FSL version 4.1.9
(17,18). Images were corrected for head motion and
eddy currents. Field maps were acquired with a spiral
sequence in the same spatial locations as the diffu-
sion-weighted images. These field maps were used to
unwarp the diffusion-weighted images due to the
echo-planar imaging readout of the DTI sequence. The
final corrected images were used to calculate tensor
elements. The tensor elements were subsequently
used to determine FA, AD, and RD (16,19).
Tract-Based Spatial Statistics
Voxel-wise statistical analyses of all three DTI maps
were carried out using tract-based spatial statistics
(TBSS v1.2) (20), a part of FSL. Whole-brain, voxel-
wise group comparison was then performed using a
permutation-based nonparametric inference t-test
within the general linear model framework using
10,000 permutations (21). T-value maps were aug-
mented using threshold free cluster enhancement (22)
and considered significant at P0.05.
Corpus Callosum VOI Drawing and DTI
Extractions From CC Regions
A standard mask was drawn of the CC to extract DTI
metrics from individual DTI maps in the following
manner. Anatomical imaging data from this cohort
indicate that gross size differences do not exist
between these patients and healthy controls (23).
Therefore, a single mask was drawn guided by the
FMRIB58 template in MNI space in the mid-sagittal
slice for application to all subjects’ data. The whole
CC mask was auto-segmented using an in-house
MATLAB program (MATLAB, MathWorks Inc.
R2011b), described previously (23). This CC mask
was then segmented geometrically with another in-
house MATLAB program into five sub-regions as
defined by Hofer (24) (their Fig. 3). The Hofer interpre-
tation of this data, guided by tractography in human
subjects, takes into account findings that suggest
fibers connecting the primary motor cortices are more
posterior in humans than in primates. These seg-
mented regions were functionally defined as: Area I,
the region that connects the caudal orbital prefrontal,
inferior premotor cortices, and prefrontal cortices;
Area II, the region that connects the premotor, cingu-
late motor, presupplementary and supplementary
motor areas; Area III, the primary focus of this analy-
sis, contains the fibers that connect the primary
motor cortices; Area IV, connecting primary sensory
cortices; and Area V, containing superior temporal,
posterior parietal, occipital, and inferior temporal cor-
tex fibers (24).
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Each of the five CC areas was expanded to the right
and left along the X-axis by 8 mm, constrained to the
FMRIB58 template. The subsequent VOI of the CC
regions were eroded to minimize partial volume effects
on values located on the edges of the VOI. These final CC
area masks were used to extract FA, AD, and RD values
from TBSS-registered nonskeletonized whole-brain data.
ANCOVA Using DTI by CC Region
An analysis of covariance (ANCOVA) was performed to
test for a main effect between patient group membership
incorporating all DTI changes within the CC. Given the
wide range of age in both comparison groups, age was
included as a covariate in the model. This analysis was
performed separately with mean FA, RD, and AD values.
Results were considered significant at a nominal signifi-
cance level, a, set to 0.05. In the ANCOVA analyses yield-
ing a significant effect, post hoc, two-tailed independent
sample t-tests of DTI mean extracted values were per-
formed to compare microstructural changes in all five CC
areas and thus confirm which CC areas are most
affected. Results were considered significant for P values
below a Bonferroni-corrected a of 0.01. Importance of
CC-area contribution to change in the CC was determined
by the magnitude in CC-area change between groups.
Correlation Analysis Between Structural and
Clinical Measures of Disease Severity
Driven by our hypothesis that CC Area III would be
most affected by motor neuron degeneration com-
pared with other CC regions, a targeted analysis of
the relationship between DTI measures in Area III and
clinical measures was performed in the patient group.
A partial correlation analysis was conducted with age
controlled in each comparison. These clinical meas-
ures include the ALSFRS-r cumulative score, disease
duration defined by months since symptom onset,
and hand strength disparity. Correlation coefficients
were considered significant at a level of a¼0.05 using
a two-tailed test. All clinical correlations were carried
out in SPSS release version 20.0.0 (SPSS Inc., an IBM
Company, 1989, 2010).
RESULTS
Group Demographics and Clinical Data
Group averages are presented in Table 1, and individ-
ual patient data are shown in Table 2. Because many
of the limb-onset patients did not identify lateraliza-
tion of symptom onset (see Table 2), analysis of MR
results proceeded without image mirroring as per-
formed in recent neuroimaging studies (8).
TBSS DTI: Decreased FA and Increased AD & RD
in ALS Patients
All DTI differences described below are significant
(P0.05, corrected for multiple comparisons). The
ICBM-DTI-81 white-matter labels atlas (25) was used
to describe anatomical locations of DTI changes.
Table 1
Mean Demographics Values for Patient (ALS) and Healthy Control (HC) Groups
Subject Gender Age (y) Handedness
Dominant
H.S. (kg) ND H.S. (kg)
Disease
duration (mo) ALSFRS-r
ALS (n¼21) 13 M, 8 F 59.8 (6 6.5,
45.9–68.5)
20R, 1L 19.05 (0–48.94) 16.36 (0–42.42) 20.48 (616.82) 37.86 (65.77,
26–46)







H.S.¼hand strength. ND H.S.¼non-dominant hand strength; ALSFRS-r¼ALS functional rating scale, revised version (total possible
score is 48).
Table 2










1 M 65.1 R 0.61 UEs 29 12.07
2 F 56.5 R 2.28 Left LE 33 26.07
3 M 60.6 R 14.39 Left LE 44 26.97
4 M 58.1 R 11.52 Bulbar 40 16.67
5 F 68.5 R 3.63 Bulbar 37 14.00
6 F 61.4 R 10.61 UE & LE 42 9.46
7 M 55.5 R 9.09 Right UE 43 14.73
8 F 67.8 R 0.76 Bulbar 43 10.17
9 F 65.8 R 7.42 Left LE 33 15.90
10 M 66.8 R 3.03 LEs 40 7.77
11 M 51.9 R 12.88 Left UE 31 11.80
12 M 64.8 R N/Aa Right LE 45 12.07
13 M 56.7 R 0.75 Bulbar 39 13.17
14 M 58.3 R 10.61 Right UE 46 20.77
15 F 45.9 Rb 4.85 Left UE 33 13.63
16 M 63.8 Lc 0 UEs 33 21.03
17 M 63.3 R 5.75 LEs 38 61.70
18 F 65.9 R 4.40 Bulbar 26 56.17
19 M 47.1 R 6.51 UEs 36 56.20
20 F 55.3 R 25.00 Left UE 46 1.73
21 M 56.1 R 13.78 Left UE 38 7.80
aHand strength could not be obtained for Subject 12 at the time of
scanning.
bSubject 15 reported left-handedness before disease onset, but
due to weakness used the right hand at the time of the scan. This
patient was considered left-handed according to the Edinburgh In-
ventory (13).
cSubject 16 reported right-handedness before disease onset, but
due to weakness used the left hand at the time of the scan. This
patient was considered right-handed according to the Edinburgh In-
ventory (13).
H.S.D.¼hand strength disparity; ALSFRS-r¼ALS functional rating
scale, revised version (total possible score is 48); DD¼disease du-
ration, defined as months between symptom onset and testing
date; UE¼upper extremity; LE¼ lower extremity.
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FA was significantly reduced in the ALS patient
group compared with healthy controls in the body
and genu of the CC, extending bilaterally. Along the
CST, FA differences were seen in the superior corona
radiata bilaterally and the anterior corona radiata de-
scending into the internal capsule on the left side. FA
was reduced in the left superior longitudinal fascicu-
lus. RD was significantly increased in ALS patients.
Specifically, the body and genu of the CC showed
increases in RD, which extended laterally to the right
and left. In the CST, bilateral increases in RD were
present in the superior corona radiata extending cau-
dally through the posterior limb of the internal cap-
sule and into the midbrain. On the left side, these
changes descended further to the base of the pons.
Increases in AD in the patient group were localized to
the left superior corona radiata and the left internal
and external capsules. Thalamic tracts were involved
bilaterally and reached caudally to the level of the
midbrain on the left. There was also some involvement
of the left superior cerebellar peduncle. See Figure 1
for FA, RD, and AD results. These results are in line
with previous findings in the literature (26–28).
Given the striking difference in FA and RD maps
with regard to extent of white matter involvement, we
conducted a post hoc voxel counting of whole-brain
binary images generated for FA and RD and the union
of resulting images to calculate the ratio of white-mat-
ter involvement given by FA and RD, respectively. We
generated binary suprathreshold masks of RD and FA
at the following P values: 0.075, 0.0625, 0.050,
0.0325, 0.0250 and calculated the mean and variance
of the observed ratio. The results of this exercise
indicated that the extent of white-matter involvement
as measured by RD is approximately twice that as
measured by FA (NRD/NFA¼1.98560.192).
Figure 1. DTI TBSS P value maps fully corrected for multiple comparisons of voxel-wise differences between patients and
healthy controls for FA, RD, and AD. Results displayed at significant levels (P<0.05, fully corrected for multiple comparisons)
in Montreal Neurological Institute (MNI) standard space overlaid on the mean FA image derived from all participants. Major
fiber tracts as determined by TBSS are displayed in green. Red-yellow clusters indicate locations of significant corrected differ-
ences between patients and controls (P<0.05). Locations of images in standard space are X¼1, Y¼17, Z¼19, MNI mm.
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ANCOVA of CC Extracted Mean Values
Because no differences were seen in the TBSS results
above with respect to AD in the CC, only FA and RD
were tested in the ANCOVA analyses. FA values dem-
onstrated a significant main effect of group
(P¼4.2106) (Fig. 2). Post hoc t-tests yielded signifi-
cant differences between healthy controls and
patients in Areas II (t¼2.83, P¼0.0072) and III
(t¼3.00; P¼0.0047). Based upon CC-area mean
effect size, order of importance of CC-area contribu-
tion to the main effect was Area III (DFAIII¼0.063)
and then Area II (DFAII¼0.047). The ANCOVA for RD
values also showed a significant main effect of group
(P¼1.6105) (Fig. 2). Post hoc t-tests of RD showed
significant difference between healthy controls and
patients in Areas I (t¼2.88, P¼0.0063), II (t¼3.62,
P¼0.0008), III (t¼2.72, P¼0.0096), and V (t¼3.00,
P¼0.0047).
Mean FA and RD Values in Area III Correlate With
Clinical Measures
Results from the partial correlation between Area III
mean FA and ALSFRS-r scores showed a significant
relationship, with decreasing FA corresponding to
worsening ALSFRS-r scores (r¼0.457, P¼0.043) (Fig.
3). Mean Area III FA also correlated negatively with
disease duration (r¼0.524, P¼0.018) (Fig. 3). There
was no significant correlation with FA and hand
strength difference (r¼0.408, P¼0.074). RD values in
Area III correlated positively with disease duration
(r¼0.621, P¼0.003) but not with ALSFRS-r scores
(r¼0.351, P¼0.129) or hand strength difference
(r¼0.335, P¼0.148).
DISCUSSION
The present investigation aimed to systematically
examine diffusion properties of motor-specific func-
tional regions of the CC, guided by the well-defined
geometric scheme of Hofer and Frahm (a modification
of an earlier segmentation scheme of Witelson) (24,29)
in patients with ALS. The results confirm our hypoth-
esis that white matter deterioration within the CC
converges on transcallosal primary motor cortex
fibers, designated Area III. Notably, our study also
demonstrated decreased FA in the CC of patients with
ALS, which was driven by changes in the transcallosal
Figure 2. Mean FA and RD values for ALS patients plotted against the control group’s mean FA and RD values for each CC
area (1–5). For both DTI measures, there was a significant effect between-group membership and location in the CC, and
post hoc t-tests comparing groups by individual CC area that resulted in significant differences with Bonferroni correction
are indicated with an asterisk (*,P<0.01).
Figure 3. Scatterplots showing significant partial correlations between mean FA in Area III of the CC and ALSFRS-r scores
when correcting for age (r¼0.457, P¼0.043) and months since symptom onset when correcting for age (r¼0.524;
P¼0.018). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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regions connecting fibers between the premotor, cin-
gulate motor, presupplementary and supplementary
motor areas, collectively represented by Area II. These
results provide more convincing evidence than previ-
ously available that the degeneration of white matter
within the CC is localized to motor-specific regions.
While various DTI studies have flagged the CC as
an important location in the extra-motor network of
pathology in ALS, only one thus far has systematically
addressed the location within the CC of this damage.
This study linked FA changes with Area III in ALS
patients, but did not attempt to statistically differenti-
ate the contributions of the various functional sub-
areas of the CC (9). For this reason, our results are
noteworthy in finding the motor-related regions of the
CC most significantly affected. This significant finding
has important clinical value for the following reasons.
It has been stated that there is a need for an objec-
tive early marker for UMN impairment in ALS. Using
the current clinically guided methods of diagnosis,
disease-related neurodegeneration outside the tradi-
tional motor network of the CST is not easily observed
(2). A notable exception is the mirror movement, an
involuntary movement that mirrors that of a contra-
lateral limb. It is considered a clinical sign of transcal-
losal fiber dysfunction and has been observed in some
ALS patients (30). The presence of this sign is likely
related to white matter changes in motor regions of
the CC. Sub-clinical forms of the sign can be elicited
by applying transcranial magnetic stimulation to the
primary motor cortex and measuring neuronal excit-
ability in the ipsilateral limb. Studies with this tech-
nique showed an altered response in both definite and
probable ALS patients earlier in the disease process
(30). This indicates that the CC, in particular Area III,
may be involved early in the disease process. The
focus of that study, callosal dysfunction, relates
directly to the aims of the present investigation.
Through our study, we aimed to draw an important
connection between Wittstock’s peripherally measured
functional phenomena and our centrally observed loss
of CC structural integrity. Such comparisons may
shed more light onto the role of callosal dysfunction
in the disease process.
The clinical significance of our data is further sup-
ported in finding correlations between white matter
changes in the patient group and measures of disease
status. Specifically, patients with lowest FA in Area III
were also those with the greatest disease severity and
symptom duration. These findings indicate that DTI
changes in Area III potentially represent an objective
marker of more symptomatic disease. For this obser-
vation to be validated as a transitional sign of ALS
progression, more direct comparisons should be
approached with larger group sizes between high-
functioning and low-functioning patients in addition
to longitudinal studies.
Sub-region analysis of the CC in ALS warrants fur-
ther investigation, especially in light of previous rest-
ing state functional connectivity MRI studies that may
reflect the functional sequelae of destructive proc-
esses ongoing in this region (13,31,32). With the goal
of developing a multimodal approach to defining an
early biomarker in ALS, future studies should also
combine these functional, structural, and other imag-
ing modalities to shed light onto the role of this trans-
callosal fiber tract.
Another important finding was the qualitative ob-
servation that differences in RD between patients and
controls appear to represent a more widespread net-
work of disease involvement than FA differences. This
effect is echoed by the finding that there are signifi-
cant group differences in RD of the CC that extend
beyond Areas II and III. From the present analysis, it
is challenging to hypothesize why, at a cellular level,
RD may be more sensitive to ALS pathology than FA.
Comparisons of DTI data and corresponding histologic
observations indicate that increases in RD may repre-
sent myelin degeneration, whereas decreases in AD
correspond more to axonal injury, and decreases in
FA do not distinguish between the two types of neuro-
degeneration (33). This together with the results of
our study may suggest that a demyelinating process
is more widespread in white matter in ALS. This idea
conflicts with postmortem reports indicating that
alterations in motor neuron cell bodies and axonal
processes are at least as prominent as observations of
demyelination (4). However, our observation of
increased AD, also recently seen in ALS (34,35), could
be indicative of axonal loss. Future advances in the
understanding of the histologic correlates of different
DTI metrics would serve well to inform this
discussion.
One shortcoming of these data is that it is unclear
whether callosal involvement in the disease might pre-
date clinical evidence of the disease that physicians
currently use to make the diagnosis. Indeed, recent
longitudinal DTI data suggest that changes within the
corpus callosum may not be a sensitive reflection of
disease progression (35). The timing of callosal
involvement in ALS clearly requires further study and
certainly capturing DTI data in ALS patients earlier in
the disease process will help elucidate that involve-
ment. Where possible, it is also suggested that DTI
data be collected in patients presenting with symp-
toms but as yet diagnosed with definitive ALS.
In conclusion, this study has provided evidence that
motor and supplementary motor cortex-associated
tracts of the corpus callosum are especially affected
by the ALS disease process. A recent meta-analysis by
Foerster et al (36) demonstrated the limited diagnostic
utility of DTI, however, this analysis was limited to
mainly white matter regions outside the corpus cal-
losum and excluded approaches for whole brain anal-
ysis as we have done here. DTI examination of FA in
this region may be incorporated into a neuroimaging
biomarker, which could provide a more objective test
of UMN impairment and allow for earlier detection of
disease. Additionally, reduced FA in this region is in-
dicative of greater disease severity and duration, how-
ever previous longitudinal studies have not identified
a progressive change in this region over time. It could
be postulated that early white matter involvement in
Areas II and III represented by FA decreases could
therefore be predictive of clinical prognosis, which
ultimately would allow for increased enrollment in
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clinical trials, and more importantly, earlier targeted
clinical management. Finally, although a qualitative
observation, the more extensive involvement of white
matter as measured by RD may implicate RD as a
more sensitive measure of the ALS disease process
than FA.
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